Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Patients With Severe Mental Illness”

Showing 20 of 0 results

Not applicableLooking for participantsNCT07543328
What this trial is testing

Transcranial Photobiomodulation (tPBM) for Somatic Symptoms in Treatment-Resistant Depression

Who this might be right for
Treatment-resistant Depression (TRD)Major Depression Disorder
Taipei Veterans General Hospital, Taiwan 40
Early research (Phase 1)Not Yet RecruitingNCT07554872
What this trial is testing

Study of Neural Stem Cell-Derived Exosomes in Moderate-to-Severe Early-Onset Alzheimer's Disease

Who this might be right for
Alzheimer Disease (AD)
Shanghai Mental Health Center 9
Large-scale testing (Phase 3)Study completedNCT01110902
What this trial is testing

Efficacy, Safety and Tolerability of Agomelatine Sublingual Tablets in the Treatment of Major Depressive Disorder (MDD)

Who this might be right for
Major Depressive Disorder
Novartis Pharmaceuticals 589
Not applicableWithdrawnNCT04496505
What this trial is testing

Neuromodulation Device Use in Patients With Major Depressive Disorder

Who this might be right for
Clinical Depression
Medical Center of Aurora
Not applicableStudy completedNCT02522377
What this trial is testing

Administration of Subanesthetic Dose of Ketamine and Electroconvulsive Treatment for Treatment Resistant Depression

Who this might be right for
Treatment Resistant DepressionMajor Depressive DisorderSevere Depression
The Cleveland Clinic 15
Testing effectiveness (Phase 2)Study completedNCT06792136
What this trial is testing

ONO-1110 in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder (MDD
Ono Pharmaceutical Co., Ltd. 103
Testing effectiveness (Phase 2)Study completedNCT01735630
What this trial is testing

Efficacy and Safety Study of ELND005 as a Treatment for Agitation and Aggression in Alzheimer's Disease

Who this might be right for
Alzheimer's Disease
OPKO Health, Inc. 350
Not applicableStudy completedNCT02470026
What this trial is testing

Noradrenergic Activity, Cognition and Major Depressive Disorder

Who this might be right for
Major Depressive DisorderEarly Life Trauma
Charite University, Berlin, Germany 131
Not applicableStudy completedNCT01397903
What this trial is testing

Description of Treatment Management of Patients With Major Depressive Disorder and Inadequate Response

Who this might be right for
Major Depressive Disorder
AstraZeneca 545
Testing effectiveness (Phase 2)Looking for participantsNCT05529927
What this trial is testing

Efficacy and Safety of Sustained-release Dexamphetamine in Patients With Moderate to Severe Cocaine Use Disorder

Who this might be right for
Cocaine Use Disorder
Parnassia Addiction Research Centre 204
Not applicableStudy completedNCT01329523
What this trial is testing

Compare Genetic Variations of IGF-I and IGF-II

Who this might be right for
Dementia
Avera McKennan Hospital & University Health Center 50
Not applicableStudy completedNCT02937259
What this trial is testing

Self-admission: A New Treatment Approach for Patients With Severe Eating Disorders

Who this might be right for
Eating DisordersAnorexia NervosaBulimia Nervosa
Karolinska Institutet 34
Large-scale testing (Phase 3)Study completedNCT00388973
What this trial is testing

Efficacy and Safety Study of Seroquel SR in the Treatment of Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
AstraZeneca 338
Post-approval studies (Phase 4)Study completedNCT05181527
What this trial is testing

Repurposing of Dextromethorphan as an Adjunct Therapy in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
All India Institute of Medical Sciences, Bhubaneswar 60
Post-approval studies (Phase 4)Study completedNCT00810069
What this trial is testing

Early Versus Delayed Switch in Medication in Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 840
Not applicableNot Yet RecruitingNCT07006623
What this trial is testing

"CoMBI-SMI Multicenter Study: A Person-Centered Cognitive-Behavioral Intervention for Severe Mental Illness"

Who this might be right for
Mental Illness Persistent
Vrije Universiteit Brussel 99
Very early researchStudy completedNCT01533285
What this trial is testing

Exploratory Study on the Mood and Cytokine Levels in Female Healthy Participants and Major Depressive Disorder Patients

Who this might be right for
Major Depressive Disorder
Janssen Pharmaceutica N.V., Belgium 40
Not applicableUnknownNCT05149352
What this trial is testing

RESET-psychotherapy: the Effectiveness of Trauma-focused Therapy in Patients With Depression and Childhood Trauma

Who this might be right for
Major Depressive DisorderChildhood Trauma
Amsterdam UMC, location VUmc 158
Testing effectiveness (Phase 2)Study completedNCT05271084
What this trial is testing

Pentoxifylline as an Adjunct to Citalopram in Adult Patients With Major Depressive Disorder

Who this might be right for
Major Depressive Disorder
Hawler Medical University 100
Large-scale testing (Phase 3)Study completedNCT01808651
What this trial is testing

Fluoxetine in Major Depressive Disorder (MDD) Long-Term Dosing

Who this might be right for
Major Depressive Disorder
Eli Lilly and Company 200
Next Page

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation